Eric Pachapa sold $435k of AIR
VP-CAO & Controller at AAR CORP. 6,500 shares at an average of $66.93, traded Jan 10, 2025, filed Jan 10, 2025.
Score components
- +15RoleOfficer
- +17Trade size$435k at market
- +5Share of holdings soldSold 21% of holdings
- +15Cluster5 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001127602-25-001069, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 10, 2025 | SOpen-market sale Common Stock | -6,500 | $66.93 | $435k | 24,342 | Jan 10, 2025 |
Related signals
Other insiders at AAR CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 55Moderate | AAR CORP | John McClain Holmes III Chairman, President & CEO | $354k 5,000 shares | -1% | |
| 50Moderate | AAR CORP | Christopher A. Jessup Senior Vice President-CCO | $2.4M 33,981 shares | -48% | |
| 60Notable | AAR CORP | John McClain Holmes III Chairman, President & CEO | $8.6M 128,427 shares | -34% | |
| 40Moderate | AAR CORP | Jessica A. Garascia Senior VP, GC, CAO & Secretary | $100k 1,500 shares | -4% | |
| 52Moderate | AAR CORP | Sean M. Gillen Senior VP-CFO | $1.2M 17,385 shares | -22% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.